The role of ACE1 I/D and ACE2 polymorphism in the outcome of Iranian COVID-19 patients: A case-control study.

Faridzadeh, Arezoo; Mahmoudi, Mahmoud; Ghaffarpour, Sara; Zamani, Mohammad Saber; Hoseinzadeh, Akram; Naghizadeh, Mohammad Mehdi; Ghazanfari, Tooba.

Afiliação

Faridzadeh A; Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Mahmoudi M; Department of Immunology and Allergy, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Ghaffarpour S; Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Zamani MS; Department of Immunology and Allergy, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Hoseinzadeh A; Immunoregulation Research Center, Shahed University, Tehran, Iran.
Naghizadeh MM; Immunoregulation Research Center, Shahed University, Tehran, Iran.
Ghazanfari T; Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Front Genet ; 13: 955965, 2022.

Article em En | MEDLINE | ID: mdl-36134024